Cipla Ltd (CIPL.BO)
|Market Cap (Mil.):||Rs309,445.91|
|Shares Outstanding (Mil.):||802.92|
Cipla, through its wholly-owned subsidiary Meditab Holdings Ltd (MHL), has acquired an additional 14.5 per cent stake in Quality Chemical Industries Ltd (QCIL), Uganda, for $15 million, as per a stock market disclosure.
Nov 21 - Cipla Ltd : * Says subsidiary of co has acquired additional 14.5 percent stake in quality
* Morgan Stanley downgrades Cipla Ltd to "underweight" from "equal-weight" and reduces its target price on the stock to 386 rupees from 414 rupees citing slower growth prospects and valuations. * The bank adds that the drugmaker's move to build a marketing and sales front-end operation in the United States and Europe will yield results only in the longer term. * Morgan Stanley's downgrade comes a day after Macquarie upgraded Cipla to "outperform" from "neutral", saying the drugmaker's April-June
* Macquarie upgrades India's Cipla Ltd to "outperform" from "neutral" and raises its target price to 480 rupees from 400, saying the drugmaker's April-June earnings were "significantly above" their estimates. * Cipla on Saturday posted an 18.5 percent jump in April-June net profit to 4.75 billion rupees ($78 million). * Macquarie slightly raises its earnings estimates for fiscal years 2014 and 2015 earnings. * "We believe acceleration in export sales and comfort around sustainability of margi
(Versus the same period a year earlier, in billion rupees unless stated)